sincalide and Glaucoma

sincalide has been researched along with Glaucoma* in 1 studies

Other Studies

1 other study(ies) available for sincalide and Glaucoma

ArticleYear
Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016, Volume: 37, Issue:5

    Glaucoma is a progressive neurodegenerative disease, characterized by retinal ganglion cells (RGCs) and axon degeneration. The development of neuroprotective drug is required for improving the efficiency of glaucoma treatment. Eucommia ulmoides Oliv. has been used as a source of traditional medicine and as a beneficial health food. Lignans is one of the main bioactive components of Eucommia ulmoides. Here, we show that lignans protects RGCs against oxidative stress-induced injury in vitro. Moreover, lignans exerts neuroprotective effect on glaucoma-associated optic neuropathy in glaucomatous rats. Lignans treatment could improve oxidative stress response in RGCs and retinas of glaucomatous rats. Lignans plays an anti-oxidative stress role via the activation of AMPK signaling. This study provides evidence that lignans possesses protective effect on glaucoma-associated optic neuropathy. Lignans might be an alternative for the prevention and treatment of glaucomatous neurodegeneration.

    Topics: Animals; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Eucommiaceae; Fluoresceins; Gene Expression Regulation; Glaucoma; Hydrogen Peroxide; Lignans; Male; Neuroprotective Agents; Optic Nerve Diseases; Phosphopyruvate Hydratase; Rats; Rats, Wistar; Retinal Ganglion Cells; RNA, Long Noncoding; Signal Transduction; Sincalide; Tubulin

2016